Methods and compositions to reduce azoles and AOX corrosion inhibitors

Patent metadata

Field	Value
Publication number	US-11760666-B2
Application number	US-201916970679-A
Country	US
Kind code	B2
Filing date	Mar 1, 2019
Priority date	Mar 8, 2018
Publication date	Sep 19, 2023
Grant date	Sep 19, 2023

Abstract

A method to reduce or eliminate N-heterocycles, the method providing one or more environmentally benign chelators (EBCs) to an aqueous cooling system, the aqueous cooling system having at least one N-heterocycle in the presence of a halogenating or non-halogenating oxidizer. A method to reduce or eliminate AOX, the method providing one or more environmentally benign chelators (EBCs) to an aqueous cooling system, the aqueous cooling system having at least one AOX-containing species in the presence of a halogenating biocide.

First claim

The invention claimed is:

1. A method for inhibiting corrosion on metal surfaces in contact with an aqueous cooling system, wherein the method uses a reduced level of N-heterocycles, the method comprising:
providing one or more chelators to an aqueous cooling system, wherein the aqueous cooling system comprises:
at least one N-heterocycle in the presence of a halogenating or non-halogenating oxidizer, wherein the at least one N-heterocycle has a concentration of less than 1.0 ppm and the one or more chelators are added in a concentration greater than the concentration of the at least one N-heterocycle, and wherein the one or more chelators comprise (1) amino polycarboxylic acids, (2) polyamino acids or nucleic acids, (3) buffers, or (4) mixtures of amino alkylene phosphonic acids and their corresponding hydrolysis products.

2. The method as recited in claim 1 , wherein the amino polycarboxylic acids comprise substituted amino acids having —COOH and/or —PO3, or a combination thereof.

3. The method as recited in claim 1 , wherein the amino polycarboxylic acids comprise one or more amino functional groups, wherein the amino polycarboxylic acid is ethylenediamine tetraacetic acid, N-(2-Hydroxyethyl)ethylenediaminetriacetic acid, diethylenetriaminepentaacetic acid, Nitrilotriacetic acid, methylglycin diacetic acid (MGDA), N,N-Dicarboxymethyl glutamic acid tetrasodium salt, (2R,3R,4S,5R,6R)-3,4,6-trihydroxy-5-sulfooxyoxane-2-carboxylic acid, or Ethylenediamine-N,N′-disuccinic acid.

4. The method as recited in claim 1 , wherein the polyamino acid is polyaspartic acid or a peptide comprising more than one amino acid.

5. The method as recited in claim 1 , wherein a buffer is selected from the group consisting of N-(2-Acetamido)-2-aminoethanesulfonic acid, N-(2-acetamido)iminodiacetic acid, adenosine monophosphate, 2-amino-2-methylpropane-1,3-diol, 2-hydroxy-3-[(2-hydroxy-1,1-dimethylethyl)amino]-1-propanesulfonic acid, N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic acid, Bicine, Bis-Tris, 1,3-bis(tris(hydroxymethyl)methylamino)propane, calcium alkyl benzene sulphonate, N-cyclohexyl-3-aminopropanesulfonic acid, N-cyclohexyl-2-hydroxyl-3-aminopropanesulfonic acid, 2-(cyclohexylamino)ethanesulfonic acid, 3-(Bis(2-hydroxyethyl)amino)-2-hydroxypropane-1-sulfonic acid, 3-[4-(2-Hydroxyethyl)-1-piperazinyl]propanesulfonic acid, 4-(2-Hydroxyethyl)-1-piperazinepropanesulfonic acid, 4-(4-(2-Hydroxyethyl)piperazin-1-yl)butane-1-sulfonic acid, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 2-Hydroxy-3-(4-(2-hydroxyethyl)piperazin-1-yl)propane-1-sulfonic acid, 2-(N-morpholino)ethanesulfonic acid, 4-morpholinobutane-1-sulfonic acid, 3-(N-morpholino)propanesulfonic acid, 3-morpholino-2-hydroxypropanesulfonic acid, piperazine-N,N′-bis(2-ethanesulfonic acid), piperazine-1,4-bis(2-hydroxypropanesulfonic acid, 4-((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)butane-1-sulfonic acid, 3-((1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)propane-1-sulfonic acid, N-[tris(hydroxymethyl)methyl]-3-amino-2-hydroxypropanesulfonic acid, triethanolamine, N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid, tricine, tris(hydroxymethyl)aminomethane, or a substituted or a functionalized compound thereof.

6. The method as recited in claim 1 , wherein the amino alkylene phosphonic acids are represented by the formula (I)

wherein R 1 is —CH 2 —R 3 , —(CH 2 ) y —NR 2 or —(CH 2 ) y —NR—(CH 2 ) y —NR 2 ; and wherein R is —(CH 2 ) x —R 3 ; R 2 is —(CH 2 ) x R 3 ; and R 3 is —P0 3 or —OH, wherein R 3 is the same or different, and wherein y is between 1 and 4, and x is between 1 and 4.

7. The method as recited in claim 1 , wherein the one or more chelators can be used with a metal cationic salt comprising transition metals, p-block metals, p-block semi metals, SiO2, silicates and metal silicates, lanthanides, and actinides.

8. The method as recited in claim 1 , wherein the at least one N-heterocycle is an azole, cyclic amine, lactam, sultam, pyridine, hydro-pyridine, pyridone, pyrazine, pyrimidines, triazine, or azepin.

9. The method as recited in claim 8 , wherein the azole is an imidazolidone, oxazolidinone, hydantoin, urazole, oxazolidine, imidazolidine, isooxazolidine, pyrazolidine, pyrroline, maleimide, pyrrolin-2-one, 2-isoxazoline, 4-isoxazoline, 2-oxazoline, 3-oxazoline, 2-imidazoline, pyrrole, thiazoline, pyrazoline, 3-pyrazoline, 3H-pyrazole, imidazole, pyrazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, pentazole, oxazole, isooxazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, furazan, 1,3,4-oxadiazole, thiazole, isothiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, or a substituted or a functionalized compound thereof.

10. The method as in claim 1 , wherein the non-halogenating oxidizer comprises ClO 2 , inorganic peroxides, organic peroxides, or ozone.

11. The method as recited in claim 1 , wherein the one or more chelators can be used with a metal cationic salt comprising transition metals, p-block metals, p-block semi metals, SiO2, silicates and metal silicates, lanthanides, and actinides.

12. The method as recited in claim 1 , wherein the N-heterocycle has a concentration that is less than or equal to 0.5 ppm.

13. The method as recited in claim 1 , wherein the N-heterocycle has a concentration that is less than 0.25 ppm.

14. The method as recited in claim 1 , wherein the N-heterocycle has a concentration from 0.5 ppm to less than 1 ppm.

Assignees

• Bl Technologies Inc

Inventors

• Frail Paul Robert

Classifications

• C23F11/1676

  Phosphonic acids · CPC title

• C02F5/12

  containing nitrogen (C02F5/14 takes precedence) · CPC title

• C23F11/173

  Macromolecular compounds · CPC title

• C23F11/144

  Aminocarboxylic acids · CPC title

• C02F5/14 Primary

  containing phosphorus · CPC title